However, among TH participants and controls, depression scores based on the 6-week EPDS were similar with 22 (12.7%) and 20 (12.4%) screening positive, respectively. At 6 weeks postpartum, the most commonly reported depression symptoms based on the EPDS were feeling anxious, worried, self-blame, and "things getting on top of me." CONCLUSION: Utilizing the EPDS, our rates of depression in women with diagnosed hypertensive disorders during pregnancy are similar to national postpartum rates at 13%. Our results demonstrated that depressed mood is most common during the first week postpartum. Self-reported depressed mood may not predict actual depression. However, TH could provide a promising approach in identifying PPD earlier by utilizing more sensitive questions based on EPDS commonly reported feelings, prompting earlier intervention and treatment. This is an approach that warrants future investigation.
OBJECTIVE: Cardiac disease is a significant contributor to severe maternal morbidity (SMM). The objective of our study was to assess obstetric and cardiac outcomes among pregnant women with cardiac disease managed by a multidisciplinary care team. STUDY DESIGN: This retrospective cohort study was conducted in a single-center over a 6-year period (2012) (2013) (2014) (2015) (2016) (2017) (2018) . At our center, all pregnant patients with congenital and acquired cardiac disease are cared for by a multidisciplinary team of perinatologists, cardiologists, anesthesiologists, and nurses. Monthly in-person meetings are held to coordinate the care of pregnant patients and develop detailed delivery and postpartum care plans including intrapartum monitoring, labor analgesia, and postpartum location. Peripartum SMM at the time of delivery was defined based on CDC criteria. RESULTS: Among 136 pregnancies in 117 women, 41 (35%) had arrhythmias, of which 26% were defibrillator or pacemaker dependent. Forty-five women (38%) had undergone open cardiac surgery with 44% of those receiving anticoagulation. Ten women (7%) developed pre-eclampsia, 10 (7%) had PPROM, and 36 (26 %) had preterm birth. Fifty-four women (39%) were induced, 26% of those for worsening cardiac function. Twenty women (14%) experienced an intrapartum cardiac or thrombotic event including one woman with pulmonary edema, three with arrhythmia, and two with cardiomyopathy/heart failure. Seventy-seven women (57%) were delivered vaginally. Of the 58 cesarean sections, 26 (45%) were scheduled per interdisciplinary cardiac care team planning. All unscheduled cesarean sections were performed for obstetric or neonatal indications; none were for worsening intrapartum cardiac function. Twenty women (15%) developed a postpartum cardiac event (pulmonary edema, arrhythmia, cardiomyopathy, acute heart failure, or stroke), and 8 women (6%) were readmitted within 6 weeks. Sixteen women (12%) experienced SMM at the time of delivery with a variable annual SMM rate, ranging from 0-20% (Table 1) . CONCLUSION: Peripartum severe maternal morbidity and obstetric complications among women with cardiac disease are higher than the rate described in the general population. Given the increased morbidity, such pregnancies mandate multidisciplinary comprehensive pregnancy care and planning.
OBJECTIVE: Unintended pregnancies can be life-threatening for women with complex medical conditions, yet MFMs typically do not meet the patient until after conception. We sought to better understand the contraceptive counseling provided by non-gynecologic specialists who care for medically complex women. STUDY DESIGN: Providers across 10 non-gynecologic specialties at a single tertiary center in 2016-2017 completed an anonymous survey. The survey assessed provider demographics, counseling rates, and comfort with counseling about contraception and pregnancy risks.
We then performed a retrospective cohort study to evaluate the extent of contraceptive counseling women with 20 high-risk comorbidities received. We selected comorbidities that are frequently encountered (e.g. diabetes, hypertension), associated with high morbidity (e.g. pulmonary hypertension), or put a woman at high risk of exposure to teratogenic medications (e.g. acne, lupus). We compared comorbidities using low-, moderate-, and high-maternal morbidity classifications. We considered teratogenic medications to be those previously classified as FDA category X. RESULTS: Of 200 providers approached, 158 responded (79%). Of respondents, 77% felt that it was the responsibility of all providers (primary care, gynecologist, and specialist) to counsel the patient about the risks of pregnancy; 60% felt that these same providers were responsible for counseling about contraceptive options. Over 40% of respondents reported providing contraceptive counseling "always" or "most of the time," and over 35% reported offering contraception "always" or "most of the time." Additionally, 40% of respondents reported counseling women about the risks of pregnancy; however, contraception was documented for only 36% of all Poster Session IV ajog.org women and recommended to 5% of women with high-risk medical conditions or taking a teratogenic medication. The risks of pregnancy or medication were rarely documented. CONCLUSION: While non-gynecologic specialists feel that contraceptive counseling is their responsibility, they do not routinely document counseling nor refer them to a gynecologist. OB and MFMs must provide more outreach to subspecialists who care for these women to help prevent unintended pregnancies in women at high risk of perinatal morbidity. Hadassah Medical Center, Jerusalem, Israel OBJECTIVE: Gestational thrombocytopenia (GT) accounts for 75% of cases of thrombocytopenia in pregnancy. In most cases of GT, thrombocytopenia is mild (100-150 X 10 9 /L) and has no consequences for either the mother or the fetus. We aimed to investigate the characteristics, neonatal risk and recurrence rate of GT with a platelet count <100 X 10 9 /L. STUDY DESIGN: We reviewed the records of women who delivered during 2006-2016 at a large tertiary care university hospital, and who had platelet count <100 X 10 9 /L during pregnancy. RESULTS: Of 97 pregnancies in which platelet count lower than 100 X 10 9 /L was encountered, 66 (68%) were diagnosed as GT and 31 (32%) as new-onset immune-thrombocytopenic purpura (ITP). The proportions of women with onset of thrombocytopenia in early pregnancy (P¼0.004) and a lower maternal nadir platelet count (P¼0.01) were higher among those with new-onset ITP than GT. Neonatal thrombocytopenia (<100 X 10 9 /L) was encountered following comparable proportions of pregnancies of women with new-onset ITP and GT (16.1% vs. 10.6%, P¼0.51). Among women with GT, the rate of neonatal thrombocytopenia was higher in those who experienced antepartum bleeding (P¼0.009) and in whom the onset of thrombocytopenia was in early pregnancy (P¼0.002). Of 40 subsequent pregnancies, a recurrence of GT (<100 X 10 9 /L) was encountered in 22 (55%), with similar maternal and perinatal outcomes compared to the initial pregnancy. CONCLUSION: The risk of neonatal thrombocytopenia was substantial and similar in GT and new-onset ITP. The recurrence rate of GT was high in subsequent pregnancies.
